We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$134B
AUM Growth
+$5.27B
Cap. Flow
-$1.78B
Cap. Flow %
-1.33%
Top 10 Hldgs %
41.82%
Holding
299
New
14
Increased
71
Reduced
174
Closed
22

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$950M
2
SHOP icon
Shopify
SHOP
+$562M
3
SE icon
Sea Limited
SE
+$400M
4
NU icon
Nu Holdings
NU
+$325M
5
PBR icon
Petrobras
PBR
+$300M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.19B
2
TSM icon
TSMC
TSM
+$531M
3
TSLA icon
Tesla
TSLA
+$373M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$298M
5
MELI icon
Mercado Libre
MELI
+$296M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.69%
2 Technology 25.52%
3 Communication Services 14.86%
4 Healthcare 11.39%
5 Financials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZUO
176
DELISTED
Zuora, Inc.
ZUO
$21.2M 0.02%
2,454,747
-175,228
-7% -$1.55M
VECO icon
177
Veeco
VECO
$3.23B
$20.9M 0.02%
631,011
+153,754
+32% +$5.76M
IPGP icon
178
IPG Photonics
IPGP
$3.84B
$20.8M 0.02%
280,347
+1,053
+0.4% +$78.7K
RXST icon
179
RxSight
RXST
$260M
$20.7M 0.02%
419,004
+60,789
+17% +$3.11M
MSA icon
180
Mine Safety
MSA
$7.49B
$20.6M 0.02%
116,230
-5,909
-5% -$1.07M
BUR icon
181
Burford Capital
BUR
$971M
$19.8M 0.01%
1,493,009
-41,659
-3% -$553K
PGR icon
182
Progressive
PGR
$125B
$19.7M 0.01%
77,756
+700
+0.9% +$163K
MRSH
183
Marsh
MRSH
$91.5B
$19.1M 0.01%
+85,600
New +$19M
EXAI
184
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$18.8M 0.01%
3,848,276
-549,342
-12% -$2.88M
AMBA icon
185
Ambarella
AMBA
$3.81B
$18.5M 0.01%
328,451
+2,215
+0.7% +$118K
VIR icon
186
Vir Biotechnology
VIR
$1.49B
$17.8M 0.01%
2,383,029
-1,538,213
-39% -$13.4M
CSL icon
187
Carlisle Companies
CSL
$15.4B
$17.7M 0.01%
39,289
-2,060
-5% -$852K
OSCR icon
188
Oscar Health
OSCR
$8.61B
$17.4M 0.01%
822,088
CRSP icon
189
CRISPR Therapeutics
CRSP
$5.17B
$17.1M 0.01%
364,768
-40,657
-10% -$2.06M
NKE icon
190
Nike
NKE
$61.9B
$16.2M 0.01%
182,830
+17,978
+11% +$1.41M
ADAP
191
DELISTED
Adaptimmune Therapeutics
ADAP
$15.9M 0.01%
16,775,860
+1,626,657
+11% +$1.85M
DMRC icon
192
Digimarc Corp
DMRC
$178M
$15.6M 0.01%
580,433
-17,889
-3% -$527K
ERII icon
193
Energy Recovery
ERII
$443M
$15.2M 0.01%
+876,188
New +$13.8M
MNST icon
194
Monster Beverage
MNST
$88.5B
$14.8M 0.01%
+284,051
New +$14.1M
PGNY icon
195
Progyny
PGNY
$2.2B
$14.7M 0.01%
875,837
+4,840
+0.6% +$116K
TJX icon
196
TJX Companies
TJX
$178B
$14.6M 0.01%
124,319
-2,230
-2% -$256K
EW icon
197
Edwards Lifesciences
EW
$51.7B
$13.8M 0.01%
208,696
-143,607
-41% -$10.4M
BEPC icon
198
Brookfield Renewable
BEPC
$6.26B
$13.7M 0.01%
418,371
-111,395
-21% -$3.23M
WEC icon
199
WEC Energy
WEC
$35.1B
$13.5M 0.01%
140,629
+5,008
+4% +$444K
CRL icon
200
Charles River Laboratories
CRL
$12.8B
$13.5M 0.01%
68,585
+1,048
+2% +$218K

Similar funds

Baillie Gifford & Co's Q3 2024 Portfolio in Review

As of Q3 2024, Baillie Gifford & Co held 299 positions worth $134B, up 4.1% from $128B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Baillie Gifford & Co's Q3 2024 filing shows 14 new, 71 increased, 174 reduced and 22 closed positions. Its largest new stake was Dutch Bros: 7,007,836 shares worth $224M. The largest sale was NVIDIA, an estimated $2.19B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

  • Baillie Gifford & Co's largest Q3 2024 buy was Dutch Bros: 7,007,836 shares worth $224M.
  • Baillie Gifford & Co added most to Microsoft in Q3 2024, an estimated $950M increase.
  • Baillie Gifford & Co's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $2.19B.
  • Baillie Gifford & Co fully exited Adobe in Q3 2024, selling an estimated $228M.
  • Baillie Gifford & Co's ten largest holdings make up 42% of its $134B portfolio in Q3 2024.
  • Baillie Gifford & Co opened 14 new positions and closed 22 in Q3 2024.
  • Baillie Gifford & Co's portfolio value rose 4.1% quarter-over-quarter to $134B.

Based on Baillie Gifford & Co's 13F filing for Q3 2024, filed 5 Nov 2024.